Table 2.
Risk factors for transmission of MERS-CoV in all patient contacts and in patients in group A
| Odds ratio (95% CI) | p value | ||
|---|---|---|---|
| All patient contacts (n=675) | |||
| Age (>60 years) | 1·43 (0·62–3·28) | 0·71 | |
| Male | 0·77 (0·35–1·71) | 0·48 | |
| Any underlying disease | 1·97 (0·79–5·41) | 0·12 | |
| Group | <0·0001 | ||
| A vs B | 4·32 (1·22–24·49)* | 0·016* | |
| A vs C | 25·59 (8·22–111·39)* | <0·0001* | |
| Group A (n=117) | |||
| Stay in the same zone as Patient 14 for >2 h | 1·74 (0·48–8·37) | 0·42 | |
| Location of exposure to Patient 14 | 0·010 | ||
| Zone II vs III | 0·91 (0·23–3·83)* | 1·00* | |
| Zone II vs IV | 5·62 (1·25–36·84)* | 0·019* | |
MERS-CoV=Middle East respiratory syndrome coronavirus.
*
Bonferroni's correction.